Targeting P2 receptors--current progress in treating musculoskeletal diseases

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Purinergic signaling, involving extracellular nucleotides and purinergic receptors, is a fundamental and widespread biological process.
• P2 receptors (P2X and P2Y subtypes) have been implicated in musculoskeletal system functions since the early 1990s.

Purpose of the Study:

• To review recent significant developments in purinergic signaling within the musculoskeletal system.
• To highlight the pharmaceutical potential arising from these advancements.

Main Methods:

• Literature review of recent research (past five years) on P2 receptors in musculoskeletal systems.
• Synthesis of findings related to P2 receptor function and therapeutic applications.

Main Results:

• Significant progress has been made in understanding P2 receptor roles in musculoskeletal tissues.
• Emerging data suggests considerable pharmaceutical opportunities for P2 receptor modulation.

Conclusions:

• Purinergic signaling is integral to musculoskeletal health and disease.
• Targeting P2 receptors offers promising therapeutic avenues for musculoskeletal disorders.